Mon, 19 Mar 2012 | BUSINESS SALE
Engineering firm Mouchel has brought in Goldman Sachs to advise on a possible sale as it looks to tackle its £90 million debt pile.
Options to be considered include a debt-for-equity swap - which would wipe out existing shareholders and pass control over to Mouchel’s lenders - a new share issue to raise funds and a break-up and sale.
The Sunday Times reported that Glynn Thomas, previously the corporate development director at VT Group, has been brought in to assist Mouchel’s chief executive, Grant Rumbles, with strategy.
During his time at VT Mr Thomas had failed in an attempt to purchase Mouchel. It is believed he will be acting as adviser to Mr Rumbles on a potential sale.
In 2011 London-based Mouchel entered rescue talks with its main bank lenders – RBS, Lloyds and Barclays – after a large profit downgrade following the discovery of a deep hole in its accounts.
Mouchel had miscalculated its profits on a project by £4.3 million after an actuarial error on its pensions. In addition to this, it was uncovered that a further £4.3 million needed to be put to one side after aggressive accounting on some of its contracts came to light.
Mouchel has offices in the UK, Ireland, the Middle East and Africa. It is market leading in water, public health, power, highways and structural engineering.
The company is a leading manufacturer of cabling equipment for use across a variety of industries. With UK market dominance, the company also has an international customer base and receives recurring business through service and maintenance contracts...
A long-established distributor of bicycle components, accessories and maintenance products which supplies more than 1,000 retail and online shops across the UK has been placed in administration. Offers are now invited by 5pm on Monday, June 30, 2025.
The company is a prominent provider of installation, commissioning, and repair services for water purification systems, serving over 30 active clients across diverse sectors such as energy, industrial, healthcare, and pharmaceuticals. With a strong r...
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.